News & AnalysisGenomics

Researchers to Explore Promise, Risks of Sequencing Newborns' DNA

Science  13 Sep 2013:
Vol. 341, Issue 6151, pp. 1163
DOI: 10.1126/science.341.6151.1163

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

U.S. geneticists last week began examining the promise and risks of sequencing every newborn's genome. DNA sequencing could improve the accuracy of state newborn screening programs that test babies' blood for biochemical markers for several dozen rare disorders. And genome testing could potentially look for all 7000 or so diseases caused by defects in single genes. But newborn genome testing could potentially reveal many more unexpected genetic risks. Should parents be told, for example, that their child is at high risk for cancer later in life? A new $25 million, 5-year federal research program will examine such questions.

Related Content